#CommercialStrategy

40:40 Recruitment - celia@4040recruitment.co.uk

@4040rec.bsky.social

3 months ago

Day 4 – “Four #Keywords Optimised On the fourth day of #Xmas, #4040Rec sent to you… 🎁 Four #strongkeywords in your #CV & #profile! Think industry-specific: ✨ #Pharma ✨ #Healthcare ✨ #Insights ✨ #CommercialStrategy
#Recruiters and online systems often search by keywords —make sure you’re found

Daily Maverick

@dailymaverick.co.za

3 months ago

What a Growth Partner owns (and what they don’t) | Daily Maverick

SPONSORED CONTENT: Is your growth feeling jittery? Effort isn't the issue, ownership is. A Growth Partner accelerates success by owning the commercial system end-to-end, moving beyond activity to achieve clarity and accountability.

#GetSet #GrowthPartner #CommercialStrategy

Lumanity

@lumanity.bsky.social

3 months ago

We’re looking forward to next week's #PHLEXSummit! Will you be in attendance? If so, reach out to contact@lumanity.com to schedule time to meet with us on-site. For more info on the summit: buff.ly/wld2kKE

#LaunchExcellence #CommercialStrategy #PharmaLandscape #PHLEX

40:40 Recruitment - celia@4040recruitment.co.uk

@4040rec.bsky.social

3 months ago

Looking for your next move in #pharma or #healthcare?#4040Rec work on #commercial & #marketing roles at all levels across the #lifesciencesindustry. If you work in:
💊 #Pharma 🏥 #Healthcare 📈 #Marketing 🎯 #CommercialStrategy We want to hear from you!👉 Register your CV at:info@4040recruitment.co.uk

iNetwork

@i-network.bsky.social

3 months ago

Thank you to Stuart Bellerby for joining us at the Annual Conference today!

There are some big ideas from Stuart's session on Generating New Commercial Opportunities!
Innovation opens doors – and we’re ready to walk through them.
#CommercialStrategy #GrowthBig #iNetwork2025

Vinetur Global

@vineturglobal.bsky.social

6 months ago

Pernod Ricard USA restructures commercial strategy to target growth in ready-to-drink and emerging brands New divisions and distributor partnerships aim to boost market share as consumer preferences shift and global sales fluctuate

FYI: Pernod Ricard USA restructures commercial strategy to target growth in ready-to-drink and emerging brands #PernodRicard #ReadyToDrink #EmergingBrands #CommercialStrategy #MarketShare

pharmaphorum

@pharmaphorum.bsky.social

6 months ago

Lundbeck retreats from dozens of markets, slashing staff Lundbeck has announced a major change to its commercial strategy, withdrawing from 27 markets and handing day-to-day operations to partners.

#Lundbeck has announced a major change to its #commercialstrategy, withdrawing from 27 markets and handing day-to-day operations to #partnercompanies.

@drelity.bsky.social

6 months ago

Ever been in a meeting where the tech team is speaking one language and the commercial team another?

That's exactly what we solve. We sit in that sweet spot between technical complexity and commercial clarity.

#cybermarketing #infosecmarketing #CommercialStrategy #TechBusiness

Lumanity

@lumanity.bsky.social

9 months ago

We're thrilled to announce a partnership with the Parker Institute for Cancer Immunotherapy (PICI), a collaborative consortium of the world’s leading #immunooncology experts. Learn more at buff.ly/PaBQ7J1

#Immunotherapy #ImmunoTherapies #Oncology #Cancer #Pharma #Biotech #CommercialStrategy #ASCO

The ConTech Crew

@thecontechcrew.bsky.social

9 months ago

Strategy-first thinking kills good work.

🎧 Listen to the full episode https://youtu.be/pfcBhDWv9dk

#constructionmanagement #vendorrelations #commercialstrategy #transparencyatwork #projectsuccess #scopeisking #contractormanagement #buildbetter #constructiontech #projectrisk

FirstWord Group

@firstwordgroup.com

10 months ago

Join experts from Pfizer, GSK, and S3 Connected Health as they explore how to measure real business impact across branded companion products, above-brand solutions, and PDURs. Register here us02web.zoom.us/webinar/regi...

#biopharma #commercialstrategy #digitalhealth #healthtech #medaffairs #pharma

Profit Trading USA

@profittradingusa.bsky.social

11 months ago

Novo Nordisk’s head of commercial strategy steps down By Maggie Fick and Stine Jacobsen LONDON/COPENHAGEN (Reuters) - Novo Nordisk (NYSE:NVO)’s head of commercial strategy and corporate affairs, Camilla Sylvest, has decided to leave the company, the Danish drugmaker said on Thursday. Novo’s rare disease unit head, Ludovic Helfgott, who was already on the executive management team, will immediately assume the responsibility for product and portfolio strategy, including commercial strategy, medical affairs and business development across all therapy areas, the company said. Sylvest was one of two women on Novo’s 10-person executive management team. Well known to investors and analysts, she was a consistent presence alongside Chief Executive Officer Lars Fruergaard Jorgensen, Chief Financial Officer Karsten Munk Knudsen, and others on earnings calls. Novo’s statement on Thursday said that Sylvest had decided to leave and did not cite a reason. While some European pharmaceutical companies - including Swiss drugmakers Roche and Novartis (SIX:NOVN) - have abandoned global diverse workforce targets in response to recent U.S. executive orders, Novo Nordisk says it remains committed to its DEI programmes.

Click Subscribe #NovoNordisk #CommercialStrategy #BusinessNews #ExecutiveChanges #Pharmaceuticals